164 related articles for article (PubMed ID: 18971123)
1. Insulin, insulin-like growth factors and neoplasia.
Pollak M
Best Pract Res Clin Endocrinol Metab; 2008 Aug; 22(4):625-38. PubMed ID: 18971123
[TBL] [Abstract][Full Text] [Related]
2. Biological & physiological aspects of action of insulin-like growth factor peptide family.
Pavelić J; Matijević T; Knezević J
Indian J Med Res; 2007 Apr; 125(4):511-22. PubMed ID: 17598937
[TBL] [Abstract][Full Text] [Related]
3. The insulin receptor/insulin-like growth factor receptor family as a therapeutic target in oncology.
Pollak M
Clin Cancer Res; 2012 Jan; 18(1):40-50. PubMed ID: 22215905
[TBL] [Abstract][Full Text] [Related]
4. Insulin-like growth factors and neoplasia.
Pollak MN
Novartis Found Symp; 2004; 262():84-98; discussion 98-107, 265-8. PubMed ID: 15562824
[TBL] [Abstract][Full Text] [Related]
5. Alteration of the insulin-like growth factor axis during in vitro differentiation of the human osteosarcoma cell line HOS 58.
Viereck V; Siggelkow H; Pannem R; Braulke T; Scharf JG; Kübler B
J Cell Biochem; 2007 Sep; 102(1):28-40. PubMed ID: 17372931
[TBL] [Abstract][Full Text] [Related]
6. The insulin-like growth factor system and sarcomas.
Rikhof B; de Jong S; Suurmeijer AJ; Meijer C; van der Graaf WT
J Pathol; 2009 Mar; 217(4):469-82. PubMed ID: 19148905
[TBL] [Abstract][Full Text] [Related]
7. The rationale and development of therapeutic insulin-like growth factor axis inhibition for lung and other cancers.
Camidge DR; Dziadziuszko R; Hirsch FR
Clin Lung Cancer; 2009 Jul; 10(4):262-72. PubMed ID: 19632946
[TBL] [Abstract][Full Text] [Related]
8. Obesity, hyperinsulinemia and breast cancer: novel targets and a novel role for metformin.
Wysocki PJ; Wierusz-Wysocka B
Expert Rev Mol Diagn; 2010 May; 10(4):509-19. PubMed ID: 20465505
[TBL] [Abstract][Full Text] [Related]
9. Signalling pathways of insulin-like growth factors (IGFs) and IGF binding protein-3.
Martin JL; Baxter RC
Growth Factors; 2011 Dec; 29(6):235-44. PubMed ID: 21895551
[TBL] [Abstract][Full Text] [Related]
10. Insulin-Like Growth Factor (IGF) family and prostate cancer.
Gennigens C; Menetrier-Caux C; Droz JP
Crit Rev Oncol Hematol; 2006 May; 58(2):124-45. PubMed ID: 16387509
[TBL] [Abstract][Full Text] [Related]
11. Disrupting insulin-like growth factor signaling as a potential cancer therapy.
Sachdev D; Yee D
Mol Cancer Ther; 2007 Jan; 6(1):1-12. PubMed ID: 17237261
[TBL] [Abstract][Full Text] [Related]
12. The insulin-like growth factor system in multiple myeloma: diagnostic and therapeutic potential.
Bieghs L; Johnsen HE; Maes K; Menu E; Van Valckenborgh E; Overgaard MT; Nyegaard M; Conover CA; Vanderkerken K; De Bruyne E
Oncotarget; 2016 Jul; 7(30):48732-48752. PubMed ID: 27129151
[TBL] [Abstract][Full Text] [Related]
13. Insulin-like growth factor receptor expression is associated with aggressive phenotypes and has therapeutic activity in biliary tract cancers.
Ohashi H; Adachi Y; Yamamoto H; Taniguchi H; Nosho K; Suzuki H; Arimura Y; Imai K; Carbone DP; Shinomura Y
Cancer Sci; 2012 Feb; 103(2):252-61. PubMed ID: 22044563
[TBL] [Abstract][Full Text] [Related]
14. Insulin-like growth factors and aging.
Hammerman MR
Endocrinol Metab Clin North Am; 1987 Dec; 16(4):995-1011. PubMed ID: 3322823
[TBL] [Abstract][Full Text] [Related]
15. Plasma and tissue insulin-like growth factor-I receptor (IGF-IR) as a prognostic marker for prostate cancer and anti-IGF-IR agents as novel therapeutic strategy for refractory cases: a review.
Ozkan EE
Mol Cell Endocrinol; 2011 Sep; 344(1-2):1-24. PubMed ID: 21782884
[TBL] [Abstract][Full Text] [Related]
16. The insulin-like growth factor system.
Le Roith D
Exp Diabesity Res; 2003; 4(4):205-12. PubMed ID: 14668044
[TBL] [Abstract][Full Text] [Related]
17. IGF, IGF receptor and overgrowth syndromes.
Bentov I; Werner H
Pediatr Endocrinol Rev; 2004 Jun; 1(4):352-60. PubMed ID: 16437028
[TBL] [Abstract][Full Text] [Related]
18. Development of multitargeted inhibitors of both the insulin-like growth factor receptor (IGF-IR) and members of the epidermal growth factor family of receptor tyrosine kinases.
Hubbard RD; Bamaung NY; Fidanze SD; Erickson SA; Palazzo F; Wilsbacher JL; Zhang Q; Tucker LA; Hu X; Kovar P; Osterling DJ; Johnson EF; Bouska J; Wang J; Davidsen SK; Bell RL; Sheppard GS
Bioorg Med Chem Lett; 2009 Mar; 19(6):1718-21. PubMed ID: 19217287
[TBL] [Abstract][Full Text] [Related]
19. The insulin-like growth factor system in kidney disease and hypertension.
Bach LA
Curr Opin Nephrol Hypertens; 2012 Jan; 21(1):86-91. PubMed ID: 22123209
[TBL] [Abstract][Full Text] [Related]
20. The growth hormone-insulin-like growth factor axis in glycogen storage disease type 1: evidence of different growth patterns and insulin-like growth factor levels in patients with glycogen storage disease type 1a and 1b.
Melis D; Pivonello R; Parenti G; Della Casa R; Salerno M; Balivo F; Piccolo P; Di Somma C; Colao A; Andria G
J Pediatr; 2010 Apr; 156(4):663-70.e1. PubMed ID: 20022338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
